Terms: = Leukemia AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP
387 results:
1. Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells.
Zeng C; Nie D; Wang X; Zhong S; Zeng X; Liu X; Qiu K; Peng X; Zhang W; Chen S; Zha X; Chen C; Chen Z; Wang W; Li Y
Mol Cancer; 2024 Oct; 23(1):240. PubMed ID: 39465372
[TBL] [Abstract] [Full Text] [Related]
2. E41K mutation activates Bruton's tyrosine kinase by stabilizing an inositol hexakisphosphate-dependent invisible dimer.
Chowdhury S; Chakraborty MP; Roy S; Dey BP; Gangopadhyay K; Das R
J Biol Chem; 2024 Aug; 300(8):107535. PubMed ID: 38971313
[TBL] [Abstract] [Full Text] [Related]
3. LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway.
Wang H; Wang L; Luan H; Xiao J; Zhao Z; Yu P; Deng M; Liu Y; Ji S; Ma J; Zhou Y; Zhang J; Meng X; Zhang J; Zhao X; Li C; Li F; Wang D; Wei S; Hui L; Nie S; Jin C; An Z; Zhang N; Wang Y; Zhang CC; Li Z
J Exp Clin Cancer Res; 2024 Jul; 43(1):183. PubMed ID: 38951916
[TBL] [Abstract] [Full Text] [Related]
4. The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia.
Zheng R; Wei W; Liu S; Zeng D; Yang Z; Tang J; Tan J; Huang Z; Gao M
Cell Commun Signal; 2024 Jun; 22(1):314. PubMed ID: 38849885
[TBL] [Abstract] [Full Text] [Related]
5. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
Wen D; Xiao H; Gao Y; Zeng H; Deng J
Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
[TBL] [Abstract] [Full Text] [Related]
6. Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations.
Tawfik HO; Mousa MHA; Zaky MY; El-Dessouki AM; Sharaky M; Abdullah O; El-Hamamsy MH; Al-Karmalawy AA
Bioorg Chem; 2024 Aug; 149():107483. PubMed ID: 38805913
[TBL] [Abstract] [Full Text] [Related]
7. Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines.
Kim BR; Kim DY; Tran NL; Kim BG; Lee SI; Kang SH; Min BY; Hur W; Oh SC
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757343
[TBL] [Abstract] [Full Text] [Related]
8. CHMP5 attenuates osteoarthritis via inhibiting chondrocyte apoptosis and extracellular matrix degradation: involvement of NF-κB pathway.
Gao W; Liu R; Huang K; Fu W; Wang A; Du G; Tang H; Yin L; Yin ZS
Mol Med; 2024 Apr; 30(1):55. PubMed ID: 38664616
[TBL] [Abstract] [Full Text] [Related]
9. m
Zhao Y; Zhou Y; Qian Y; Wei W; Lin X; Mao S; Sun J; Jin J
Clin Transl Med; 2024 Apr; 14(4):e1628. PubMed ID: 38572589
[TBL] [Abstract] [Full Text] [Related]
10. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract] [Full Text] [Related]
11. FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression.
Zhang N; Shen MY; Meng QL; Sun HP; Fan FY; Yi H; Yang YJ
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130519. PubMed ID: 37952564
[TBL] [Abstract] [Full Text] [Related]
12. MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1.
Zhang C; Ye W; Zhao M; Long L; Xia D; Fan Z
Int J Oral Sci; 2023 Oct; 15(1):48. PubMed ID: 37852994
[TBL] [Abstract] [Full Text] [Related]
13. Targeting SDCBP2 in acute myeloid leukemia.
Du Y; Li LL; Chen F; Du Y
Cell Signal; 2023 Dec; 112():110889. PubMed ID: 37714445
[TBL] [Abstract] [Full Text] [Related]
14. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
Lu L; Wang J; Fang F; Guo A; Jiang S; Tao Y; Zhang Y; Li Y; Zhang K; Zhang Z; Zhuo R; Chu X; Li X; Tian Y; Ma L; Sang X; Chen Y; Yu J; Yang Y; Cao H; Gao J; Lu J; Hu S; Pan J; He H
Cell Death Dis; 2023 Aug; 14(8):518. PubMed ID: 37573405
[TBL] [Abstract] [Full Text] [Related]
15. Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca
Duong MQ; Gadet R; Treilleux I; Borel S; Nougarède A; Marcillat O; Gonzalo P; Mikaelian I; Popgeorgiev N; Rimokh R; Gillet G
Cell Death Dis; 2023 Jul; 14(6):392. PubMed ID: 37391438
[TBL] [Abstract] [Full Text] [Related]
16. Muramyl dipeptide CD10 monoclonal antibody immunoconjugates inhibited acute leukemia in nude mice.
Wang Y; Jin X; Sun Y; Zhao Y; Qu Z; Wang L; Sun L
Biosci Rep; 2023 Apr; 43(4):. PubMed ID: 37039042
[TBL] [Abstract] [Full Text] [Related]
17. Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.
Moore JE; Bloom PC; Chu CC; Bruno JE; Herne CA; Baran AM; Quataert SA; Mosmann TR; Taylor RP; Wallace DS; Elliott MR; Barr PM; Zent CS
Leuk Res; 2023 Jun; 129():107072. PubMed ID: 37003030
[TBL] [Abstract] [Full Text] [Related]
18. Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.
Mungle T; Das N; Pal S; Gogoi MP; Das P; Ghara N; Ghosh D; Arora RS; Bhakta N; Saha V; Krishnan S
Cancer Med; 2023 Feb; 12(3):3499-3508. PubMed ID: 36812120
[TBL] [Abstract] [Full Text] [Related]
19. Selenylated Imidazo[1,2
Burkner GT; Dias DA; Souza KFS; Araújo AJP; Basilio DCLS; Jacobsen FT; Moraes ACR; Silva-Filho SE; Cavalcante MFO; Moraes CAO; Saba S; Macedo MLR; Paredes-Gamero EJ; Rafique J; Parisotto EB
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677949
[TBL] [Abstract] [Full Text] [Related]
20. A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells.
Zhao T; He Q; Xie S; Zhan H; Jiang C; Lin S; Liu F; Wang C; Chen G; Zeng H
Mol Med; 2023 Jan; 29(1):10. PubMed ID: 36658493
[TBL] [Abstract] [Full Text] [Related]
[Next]